Glatiramer Acetate
Performance & EnduranceSynthetic polypeptide for multiple sclerosis, mixture of amino acids that modulates immune response.
Key Benefits
- ✓Reduces MS relapses
- ✓Immunomodulation
- ✓Different mechanism than interferons
- ✓Generally well tolerated
- ✓Daily or 3x weekly options
Dosing Information
Detailed Protocol
Administered via subcutaneous injection daily (20mg) or 3 times weekly (40mg). Rotate injection sites. Can be self-administered. Prescription required.
About Glatiramer Acetate
Glatiramer acetate (Copaxone, Glatopa) is a complex mixture of synthetic polypeptides composed of four amino acids (glutamic acid, lysine, alanine, tyrosine). It modulates immune responses in MS. FDA-approved for relapsing forms of MS.
Research Notes
FDA-approved in 1996 for MS. Well-established efficacy and safety. Better tolerability than interferons for many. Generic versions available. Standard MS therapy option.
Potential Side Effects
- •Injection site reactions very common
- •Immediate post-injection reaction (chest tightness, flushing)
- •Lipoatrophy
- •Generally well tolerated
Always consult with a healthcare professional before starting any peptide therapy.